Moreno Mara L, Vazquez Horacio, Mazure Roberto, Smecuol Edgardo, Niveloni Sonia, Pedreira Silvia, Sugai Emilia, Mauriño Eduardo, Gomez Juan C, Bai Julio C
Small Intestine Section, Department of Medicine, Hospital de Gastroenterologa Dr. Carlos Bonorino Udaondo, Buenos Aires, and School of Medicine, Universidad del Salvador, Buenos Aires, Argentina.
Clin Gastroenterol Hepatol. 2004 Feb;2(2):127-34. doi: 10.1016/s1542-3565(03)00320-3.
Our objective in this cross-sectional, case-control study was to gain insight into celiac osteopathy by examining a well-defined cohort of patients with a wide clinical spectrum of the disease.
We studied 148 unselected celiac patients and 296 (1:2) age- and sex-matched controls diagnosed with functional gastrointestinal disorders. Based on the clinical history, 53% were classically symptomatic, 36% had subclinical celiac disease, and 11% were silent, detected by screening. The fracture information was obtained through an in-person interview using a pre-designed questionnaire.
Classically symptomatic patients had an increased number of fractures in the peripheral skeleton (47%) compared with age- and sex-matched controls (15%; odds ratio, 5.2; 95% confidence interval, 2.8-9.8). However, fractures in subclinical/silent celiac cases (20%) were no different from those in controls (14%; odds ratio, 1.7, 0.7-4.4). Compared with the subclinical/silent group, a significantly greater prevalence of fractures was detected in classically symptomatic patients (odds ratio, 3.6, 1.7-7.5). Compared with controls, celiac disease patients had significantly more fractures produced by mild trauma (P < 0.01), but there were no differences in the severity of trauma events that induced fractures. Mean bone density femoral neck z score was higher for subclinical/silent cases compared with classically symptomatic patients (P < 0.05).
Celiac patients show a very wide variation in fracture risk, with increased risk in classically symptomatic patients. Diagnostic and therapeutic strategies to prevent bone loss and fracture should be preferentially used in the subgroup of patients with classic clinical disease.
在这项横断面病例对照研究中,我们的目标是通过检查一组明确的、具有广泛临床症状谱的疾病患者,深入了解乳糜泻性骨病。
我们研究了148例未经选择的乳糜泻患者和296例(1:2)年龄和性别匹配的诊断为功能性胃肠疾病的对照者。根据临床病史,53%为典型症状患者,36%患有亚临床乳糜泻,11%为隐匿性病例,通过筛查发现。骨折信息通过使用预先设计的问卷进行面对面访谈获得。
与年龄和性别匹配的对照者(15%)相比,典型症状患者外周骨骼骨折数量增加(47%);优势比为5.2;95%置信区间为2.8 - 9.8)。然而,亚临床/隐匿性乳糜泻病例的骨折发生率(20%)与对照者(14%)无差异(优势比为1.7,0.7 - 4.4)。与亚临床/隐匿性组相比,典型症状患者骨折患病率显著更高(优势比为3.6,1.7 - 7.5)。与对照者相比,乳糜泻患者因轻度创伤导致的骨折明显更多(P < 0.01),但导致骨折的创伤事件严重程度无差异。亚临床/隐匿性病例的股骨颈平均骨密度z评分高于典型症状患者(P < 0.05)。
乳糜泻患者的骨折风险差异很大,典型症状患者风险增加。预防骨质流失和骨折的诊断和治疗策略应优先用于具有典型临床疾病的亚组患者。